PLXP stock forecast
Our latest prediction for PLx Pharma, Inc.'s stock price was made on the Aug. 21, 2020 when the stock price was at 3.97$.
In the short term (2weeks), PLXP's stock price should outperform the market by 4.63%. During that period the price should oscillate between -10.07% and +19.08%.
In the medium term (3months), PLXP's stock price should underperform the market by -5.55%. During that period the price should oscillate between -37.15% and +37.56%.Get email alerts
Create a solid portfolio with PLXP
About PLx Pharma, Inc.
PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.56$ per share.
The book value per share is 0.75$
Three months stock forecastAug. 21, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|